Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x100px

Document › Details

Genticel S.A.. (2/28/17). "Press Release: Genticel becomes “Genkyotex”. Genticel’s General Meeting Approves the Strategic Combination with GenKyoTex SA [Not for Australia, Canada, Japan, New Zealand, South Africa or the United States]". Toulouse & Geneva

	Organisation	Genticel S.A. (Euronext Paris + Brussels: GTCL)
	Today	Genkyotex S.A. (Euronext Paris + Brussels: GKTX)
	Group	Calliditas Therapeutics (Group)
	Organisation 2	Genkyotex S.A. [old, until 2/17]
	Today	Genkyotex Suisse S.A.
	Group	Calliditas Therapeutics (Group)
	Product	setanaxib (GKT831)
	Product 2	GKT771 (Genkyotex)
	Person	Papatheodorou, Elias (Genkyotex 201707 before Covagen + Medigene + Novosom + A.T.I. + Coca-Cola + Philip Morris)
	Person 2	Timmerman, Benedikt (Genticel 201304 CEO + Founder)

Original document
accessed by [iito] on 2017-04-29

Record changed: 2023-06-05

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for Calliditas Therapeutics (Group)

[1] Memo Therapeutics AG. (7/6/21). "Press Release: Memo Therapeutics AG Appoints Seasoned Executives Elias Papatheodorou as Chairman and Dr. Thomas Taapken as Member to Board of Directors". Schlieren....
[2] Calliditas Therapeutics AB. (8/25/20). "Press Release: Calliditas Appoints Group General Counsel"....
[3] Calliditas Therapeutics AB. (8/13/20). "Press Release: Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA"....
[4] Calliditas Therapeutics AB. (7/24/20). "Press Release: Calliditas Reorganizes Its Management Team"....
[5] Calliditas Therapeutics AB. (7/2/20). "Press Release: Exercise of Over-allotment Option and End of the Stabilization Period"....
[6] Calliditas Therapeutics AB. (6/5/20). "Press Release: Calliditas Therapeutics Prices Its Initial Public Offering on The Nasdaq Global Select Market in the United States"....
[7] Calliditas Therapeutics AB. (5/14/20). "Press Release: Calliditas Publicly Files Registration Statement with SEC for a Proposed Initial Public Offering in the United States"....
[8] Calliditas Therapeutics AB. (6/10/19). "Press Release: Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore"....
[9] Calliditas Therapeutics AB. (4/5/19). "Press Release: Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics". Stockholm....
[10] Calliditas Therapeutics AB. (1/8/19). "Press Release: Calliditas Therapeutics Appoints Andrew Udell to VP Commercial, North America"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]